Maintenance of ribosomal protein S19 in plasma by complex formation with prothrombin

European Journal of Haematology

Volumn 86, Issue 5, 2011, Pages 436-441

  Nishiura, Hiroshi ^a   Tanase, Sumio ^a   Tsujita, Kenichi ^a   Sugiyama, Seigo ^a   Ogawa, Hisao ^a   Nakagaki, Tomohiro ^b   Semba, Umeko ^a   Yamamoto, Tetsuro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

Gla domain; Plasma proteins; Prothrombin; Ribosomal protein S19; Warfarin treatment

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CALCIUM ION; PLASMA PROTEIN; PROTHROMBIN; RIBOSOMAL PROTEIN S19; RIBOSOME PROTEIN; THROMBIN; UNCLASSIFIED DRUG; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CHEMOTAXIS; CLINICAL ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; FEMALE; GENE MUTATION; GLOMERULUS FILTRATION; HUMAN; ISCHEMIC HEART DISEASE; MACROPHAGE; MALE; OLIGOMERIZATION; PARTIAL THROMBOPLASTIN TIME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DOMAIN; SEQUENCE ANALYSIS; THROMBOCYTE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTICOAGULANTS; BINDING SITES; BLOOD COAGULATION; BLOOD PLATELETS; CALCIUM; CROSS-LINKING REAGENTS; FACTOR X; FACTOR XIIIA; HUMANS; MULTIPROTEIN COMPLEXES; PROTEIN STRUCTURE, TERTIARY; PROTHROMBIN; RIBOSOMAL PROTEINS; WARFARIN;

EID: 79953853335     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01585.x     Document Type: Article

References (16)

1. Semba U, Chen J, Ota Y, Jia N, Arima H, Nishiura H, Yamamoto T. A plasma protein indistinguishable from ribosomal protein s19. Conversion to a monocyte chemotactic factor by a factor XIIIa-catalyzed reaction on activated platelet membrane phosphatidylserine in association with blood coagulation. Am J Pathol 2010;176:1542-51.
2. Nishiura H, Chen J, Ota Y, Semba U, Higuchi H, Nakashima T, Yamamoto T. Base of molecular mimicry between human ribosomal protein S19 dimer and human C5a anaphylatoxin. Int Immunopharmacol 2010;10:1541-7.
3. Nishimura T, Horino K, Nishiura H, Shibuya Y, Hiraoka T, Tanase S, Yamamoto T. Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer. J Biochem 2001;129:445-54.
4. Umeda Y, Shibuya Y, Semba U, Tokita K, Nishino N, Yamamoto T. Guinea pig S19 ribosomal protein as precursor of C5a receptor-directed monocyte-selective leukocyte chemotactic factor. Inflamm Res 2004;53:623-30.
5. Ota Y, Chen J, Shin M, Nishiura H, Tokita K, Shinohara M, Yamamoto T. Role of ribosomal protein S19-like plasma protein in blood coagulum resorption. Exp Mol Pathol 2011;90:19-28.
6. Nishiura H, Shibuya Y, Yamamoto T. S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a. Lab Invest 1998;78:1615-23.
7. Nishiura H, Tanase S, Sibuya Y, Nishimura T, Yamamoto T. Determination of the cross-linked residues in homo-dimerization of S19 ribosomal protein concomitant with exhibition of monocyte chemotactic activity. Lab Invest 1999;79:915-23.
8. Shibuya Y, Shiokawa M, Nishiura H, Nishimura T, Nishino N, Okabe H, Takagi K, Yamamoto T. Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer. Am J Pathol 2001;159:2293-301.
9. Filip AM, Klug J, Cayli S, et al. Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function. J Biol Chem 2009;284:7977-85.
10. Porath J, Axen R, Ernback S. Chemical coupling of proteins to agarose. Nature 1967;215:1491-2.
11. Oda Y, Tokita K, Ota Y, Li Y, Taniguchi K, Nishino N, Takagi K, Yamamoto T, Nishiura H. Agonistic and antagonistic effects of C5a-chimera bearing S19 ribosomal protein tail portion on the C5a receptor of monocytes and neutrophils, respectively. J Biochem 2008;144:371-81.
12. Nishiura H, Tanase S, Shibuya Y, Futa N, Sakamoto T, Higginbottom A, Monk P, Zwirner J, Yamamoto T. S19 ribosomal protein dimer augments metal-induced apoptosis in a mouse fibroblastic cell line by ligation of the C5a receptor. J Cell Biochem 2005;94:540-53.
13. Nishiura H, Nonaka H, Revollo IS, Semba U, Li Y, Ota Y, Irie A, Harada K, Kehrl JH, Yamamoto T. Pro- and anti-apoptotic dual functions of the C5a receptor: involvement of regulator of G protein signaling 3 and extracellular signal-regulated kinase. Lab Invest 2009;89:676-94.
14. Nakatomi Y, Nakashima T, Gokudan S, Miyazaki H, Tsuji M, Hanada-Dateki T, Araki T, Tomokiyo K, Homamoto T, Ogata Y. Combining FVIIa and FX into a mixture which imparts a unique thrombin generation potential to hemophilic plasma: an in vitro assessment of FVIIa/FX mixture as an alternative bypassing agent. Thromb Res 2010;125:457-63.
15. Nishiura H, Shibuya Y, Matsubara S, Tanase S, Kambara T, Yamamoto T. Monocyte chemotactic factor in rheumatoid arthritis synovial tissue. Probably a cross-linked derivative of S19 ribosomal protein. J Biol Chem 1996;271:878-82.
16. Collen D, de Cock F, Verstraete M. Quantification of thrombin-antithrombin III complexes in human blood. Eur J Clin Invest 1977;37:345-50.